Decoding 18 Analyst Evaluations For DexCom
Decoding 18 Analyst Evaluations For DexCom
解读德康医疗的18个分析师评估
The perception of DexCom by financial experts is...DexCom (NASDAQ:DXCM) has been analyzed by 18 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去三个月中，德康医疗（纳斯达克股票代码：DXCM）已经受到18位分析师的分析，揭示出从看好到看淡的多种观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格总结了分析师们最近的评级，揭示了过去30天内情绪的变化并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $104.22, a high estimate of $145.00, and a low estimate of $75.00. A 24.99% drop is evident in the current average compared to the previous average price target of $138.94.
营业收入增长：在为期3个月的时间段内，德康医疗（DexCom）表现积极，实现了15.26%的营业收入增长率，截至2024年6月30日。这反映了该公司顶线收益的大幅增长。与同行相比，营业收入增长率落后于行业板块内的同行。该公司的增长率低于同行的平均水平，主要集中在医疗保健板块。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细剖析
The perception of DexCom by financial experts is...
资产回报率（RO...
登录免费看全文
登录/注册